Diabetic retinopathy may be linked to higher risk for vascular disease, death

Sumary of Diabetic retinopathy may be linked to higher risk for vascular disease, death:

  • November 15, 2021 2 min read Source/Disclosures Published by: Disclosures: Modjtahedi reports receiving financial support from Genentech.
  • Please see the study for all other authors’ relevant financial disclosures.
  • Back to Healio Diabetic retinopathy may be associated with increased risk for cerebrovascular accident, myocardial infarction, congestive heart failure and all-cause mortality in patients with type 2 diabetes, according to a study in Ophthalmology.
  • “We know that diabetes is a complicated multiorgan disease that can not only impact the eyes but also increases the risk of heart attacks and strokes,” Bobeck S. Modjtahedi, MD, told Healio Optometry.
  • “In my clinical practice, I often see patients with diabetic retinopathy who eventually suffer systemic vascular complications from their underlying diabetes — heart attacks, strokes, heart failure and death,” Modjtahedi said.
  • “There [have] been some conflicting studies in the past regarding the relationship between diabetic retinopathy and systemic vascular disease;
  • ” In a retrospective cohort study, researchers examined the 5-year risk for first-time cardiovascular accident (CVA), myocardial infarction (MI), congestive heart failure (CHF) and death in patients with diabetes.
  • mean age, 59.8 years) who underwent diabetic retinopathy screening at the Kaiser Permanente Southern California Eye Monitoring Center in 2013. Patients were then divided into four groups depending on the presence and severity of retinopathy;

Want to know more click here go to source.

From -


Site Language

Popular Posts


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.